Quarterly report [Sections 13 or 15(d)]

Condensed Balance Sheets

v3.26.3
Condensed Balance Sheets - USD ($)
Sep. 30, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 9,923,000 $ 6,811,000
Restricted cash 94,000 94,000
Deferred offering costs 444,000 634,000
Prepaid expenses and other current assets 107,000 567,000
TOTAL ASSETS 10,568,000 8,106,000
Current liabilities    
Accounts payable 1,085,000 748,000
Accrued expenses 1,680,000 1,560,000
Warrant liability 11,000
Total Current Liabilities 2,765,000 2,319,000
Stockholders’ Equity    
Preferred stock value 1,000
Common stock, par value $0.001, 25,000,000 shares authorized, 2,061,052 and 1,021,366 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively 2,000 1,000
Additional paid in capital 742,813,000 729,686,000
Accumulated deficit (735,012,000) (723,901,000)
Total Stockholders’ Equity 7,803,000 5,787,000
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 10,568,000 8,106,000
Series L Preferred Stock [Member]    
Stockholders’ Equity    
Preferred stock value
Series M Preferred Stock [Member]    
Stockholders’ Equity    
Preferred stock value